Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2002 Nov;87(3):F165–F171. doi: 10.1136/fn.87.3.F165

Neonatal thyroid disorders

A Ogilvy-Stuart
PMCID: PMC1721489  PMID: 12390984

Full Text

The Full Text of this article is available as a PDF (227.9 KB).

Figure 1 .

Figure 1

Open in a new tab

Investigation of babies of mothers with thyroid disease. TSH, Thyroid stimulating hormone; fT4, free thyroxine; TSI, thyroid stimulating immunoglobulin; PTU, propylthiouracil.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ares S., Escobar-Morreale H. F., Quero J., Durán S., Presas M. J., Herruzo R., Morreale de Escobar G. Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab. 1997 Jun;82(6):1704–1712. doi: 10.1210/jcem.82.6.4019. [DOI] [PubMed] [Google Scholar]
  2. Azizi F. Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J Pediatr. 1996 Jun;128(6):855–858. doi: 10.1016/s0022-3476(96)70342-6. [DOI] [PubMed] [Google Scholar]
  3. Burrow G. N., Bartsocas C., Klatskin E. H., Grunt J. A. Children exposed in utero to propylthiouracil. Subsequent intellectual and physical development. Am J Dis Child. 1968 Aug;116(2):161–165. doi: 10.1001/archpedi.1968.02100020163007. [DOI] [PubMed] [Google Scholar]
  4. Burrow G. N., Fisher D. A., Larsen P. R. Maternal and fetal thyroid function. N Engl J Med. 1994 Oct 20;331(16):1072–1078. doi: 10.1056/NEJM199410203311608. [DOI] [PubMed] [Google Scholar]
  5. Cao X. Y., Jiang X. M., Dou Z. H., Rakeman M. A., Zhang M. L., O'Donnell K., Ma T., Amette K., DeLong N., DeLong G. R. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med. 1994 Dec 29;331(26):1739–1744. doi: 10.1056/NEJM199412293312603. [DOI] [PubMed] [Google Scholar]
  6. Chowdhry P., Scanlon J. W., Auerbach R., Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics. 1984 Mar;73(3):301–305. [PubMed] [Google Scholar]
  7. Connors M. H., Styne D. M. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins. Pediatrics. 1986 Aug;78(2):287–290. [PubMed] [Google Scholar]
  8. Crowther C. A., Hiller J. E., Haslam R. R., Robinson J. S. Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group. Pediatrics. 1997 Mar;99(3):311–317. doi: 10.1542/peds.99.3.311. [DOI] [PubMed] [Google Scholar]
  9. Daneman D., Howard N. J. Neonatal thyrotoxicosis: intellectual impairment and craniosynostosis in later years. J Pediatr. 1980 Aug;97(2):257–259. doi: 10.1016/s0022-3476(80)80487-2. [DOI] [PubMed] [Google Scholar]
  10. Davis L. E., Lucas M. J., Hankins G. D., Roark M. L., Cunningham F. G. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989 Jan;160(1):63–70. doi: 10.1016/0002-9378(89)90088-4. [DOI] [PubMed] [Google Scholar]
  11. Den Ouden A. L., Kok J. H., Verkerk P. H., Brand R., Verloove-Vanhorick S. P. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res. 1996 Jan;39(1):142–145. doi: 10.1203/00006450-199601000-00021. [DOI] [PubMed] [Google Scholar]
  12. Eisenstein Z., Weiss M., Katz Y., Bank H. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr. 1992 Aug;151(8):558–559. doi: 10.1007/BF01957719. [DOI] [PubMed] [Google Scholar]
  13. Fisher D. A., Polk D. H., Wu S. Y. Fetal thyroid metabolism: a pluralistic system. Thyroid. 1994 Fall;4(3):367–371. doi: 10.1089/thy.1994.4.367. [DOI] [PubMed] [Google Scholar]
  14. Fisher D. A. Thyroid function in premature infants. The hypothyroxinemia of prematurity. Clin Perinatol. 1998 Dec;25(4):999-1014, viii. [PubMed] [Google Scholar]
  15. Frank J. E., Faix J. E., Hermos R. J., Mullaney D. M., Rojan D. A., Mitchell M. L., Klein R. Z. Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening. J Pediatr. 1996 Apr;128(4):548–554. doi: 10.1016/s0022-3476(96)70368-2. [DOI] [PubMed] [Google Scholar]
  16. Franklin R. C., Purdie G. L., O'Grady C. M. Neonatal thyroid function: prematurity, prenatal steroids, and respiratory distress syndrome. Arch Dis Child. 1986 Jun;61(6):589–592. doi: 10.1136/adc.61.6.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fuse Y., Shimizu M., Uga N., Fujii T., Irie M. Maturation of feedback control of thyrotropin in premature infants. J Dev Physiol. 1990 Jul;14(1):17–22. [PubMed] [Google Scholar]
  18. Geffner D. L., Azukizawa M., Hershman J. M. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest. 1975 Feb;55(2):224–229. doi: 10.1172/JCI107925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Haddow J. E., Palomaki G. E., Allan W. C., Williams J. R., Knight G. J., Gagnon J., O'Heir C. E., Mitchell M. L., Hermos R. J., Waisbren S. E. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999 Aug 19;341(8):549–555. doi: 10.1056/NEJM199908193410801. [DOI] [PubMed] [Google Scholar]
  20. Hoffman W. H., Sahasrananan P., Ferandos S. S., Burek C. L., Rose N. R. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1982 Feb;54(2):354–356. doi: 10.1210/jcem-54-2-354. [DOI] [PubMed] [Google Scholar]
  21. Hollingsworth D. R., Mabry C. C. Congenital graves disease. Four familial cases with long-term follow-up and perspective. Am J Dis Child. 1976 Feb;130(2):148–155. doi: 10.1001/archpedi.1976.02120030038008. [DOI] [PubMed] [Google Scholar]
  22. Jansson R., Dahlberg P. A., Lindström B. Comparative bioavailability of carbimazole and methimazole. Int J Clin Pharmacol Ther Toxicol. 1983 Oct;21(10):505–510. [PubMed] [Google Scholar]
  23. Kalb R. E., Grossman M. E. The association of aplasia cutis congenita with therapy of maternal thyroid disease. Pediatr Dermatol. 1986 Sep;3(4):327–330. doi: 10.1111/j.1525-1470.1986.tb00534.x. [DOI] [PubMed] [Google Scholar]
  24. Kamijo K., Saito T., Sato M., Yachi A., Mukai A., Fukusi M., Takasugi N. Transient subclinical hypothyroidism in early pregnancy. Endocrinol Jpn. 1990 Jun;37(3):397–403. doi: 10.1507/endocrj1954.37.397. [DOI] [PubMed] [Google Scholar]
  25. Kampmann J. P., Johansen K., Hansen J. M., Helweg J. Propylthiouracil in human milk. Revision of a dogma. Lancet. 1980 Apr 5;1(8171):736–737. doi: 10.1016/s0140-6736(80)91233-7. [DOI] [PubMed] [Google Scholar]
  26. Karpman B. A., Rapoport B., Filetti S., Fisher D. A. Treatment of neonatal hyperthyroidism due to Graves' disease with sodium ipodate. J Clin Endocrinol Metab. 1987 Jan;64(1):119–123. doi: 10.1210/jcem-64-1-119. [DOI] [PubMed] [Google Scholar]
  27. Khoury M. J., Becerra J. E., d'Almada P. J. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study. Paediatr Perinat Epidemiol. 1989 Oct;3(4):402–420. doi: 10.1111/j.1365-3016.1989.tb00528.x. [DOI] [PubMed] [Google Scholar]
  28. Lamberg B. A., Ikonen E., Osterlund K., Teramo K., Pekonen F., Peltola J., Välimäki M. Antithyroid treatment of maternal hyperthyroidism during lactation. Clin Endocrinol (Oxf) 1984 Jul;21(1):81–87. doi: 10.1111/j.1365-2265.1984.tb00139.x. [DOI] [PubMed] [Google Scholar]
  29. Leviton A., Paneth N., Reuss M. L., Susser M., Allred E. N., Dammann O., Kuban K., Van Marter L. J., Pagano M. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr. 1999 Jun;134(6):706–711. doi: 10.1016/s0022-3476(99)70285-4. [DOI] [PubMed] [Google Scholar]
  30. Low L. C., Lang J., Alexander W. D. Excretion of carbimazole and propylthiouracil in breast milk. Lancet. 1979 Nov 10;2(8150):1011–1011. doi: 10.1016/s0140-6736(79)92575-3. [DOI] [PubMed] [Google Scholar]
  31. Lucas A., Morley R., Fewtrell M. S. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ. 1996 May 4;312(7039):1132–1134. doi: 10.1136/bmj.312.7039.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lucas A., Rennie J., Baker B. A., Morley R. Low plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child. 1988 Oct;63(10):1201–1206. doi: 10.1136/adc.63.10.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mandel S. J., Brent G. A., Larsen P. R. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid. 1994 Spring;4(1):129–133. doi: 10.1089/thy.1994.4.129. [DOI] [PubMed] [Google Scholar]
  34. Mandel S. J., Hermos R. J., Larson C. A., Prigozhin A. B., Rojas D. A., Mitchell M. L. Atypical hypothyroidism and the very low birthweight infant. Thyroid. 2000 Aug;10(8):693–695. doi: 10.1089/10507250050137770. [DOI] [PubMed] [Google Scholar]
  35. Mandel S., Hanna C., LaFranchi S. Thyroid function of infants born to mothers with Graves disease. J Pediatr. 1990 Jul;117(1 Pt 1):169–170. doi: 10.1016/s0022-3476(05)82473-4. [DOI] [PubMed] [Google Scholar]
  36. Matsuura N., Konishi J., Fujieda K., Kasagi K., Iida Y., Hagisawa M., Fujimoto S., Fukushi M., Takasugi N. TSH-receptor antibodies in mothers with Graves' disease and outcome in their offspring. Lancet. 1988 Jan 2;1(8575-6):14–17. doi: 10.1016/s0140-6736(88)91001-x. [DOI] [PubMed] [Google Scholar]
  37. McCarroll A. M., Hutchinson M., McAuley R., Montogomery D. A. Long-term assessment of children exposed in utero to carbimazole. Arch Dis Child. 1976 Jul;51(7):532–536. doi: 10.1136/adc.51.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Meijer W. J., Verloove-Vanhorick S. P., Brand R., van den Brande J. L. Transient hypothyroxinaemia associated with developmental delay in very preterm infants. Arch Dis Child. 1992 Jul;67(7):944–947. doi: 10.1136/adc.67.7.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Messer P. M., Hauffa B. P., Olbricht T., Benker G., Kotulla P., Reinwein D. Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenh) 1990 Sep;123(3):311–316. doi: 10.1530/acta.0.1230311. [DOI] [PubMed] [Google Scholar]
  40. Mestman J. H. Hyperthyroidism in pregnancy. Clin Obstet Gynecol. 1997 Mar;40(1):45–64. doi: 10.1097/00003081-199703000-00007. [DOI] [PubMed] [Google Scholar]
  41. Millar L. K., Wing D. A., Leung A. S., Koonings P. P., Montoro M. N., Mestman J. H. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994 Dec;84(6):946–949. [PubMed] [Google Scholar]
  42. Mitsuda N., Tamaki H., Amino N., Hosono T., Miyai K., Tanizawa O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol. 1992 Sep;80(3 Pt 1):359–364. [PubMed] [Google Scholar]
  43. Mol J. A., Visser T. J. Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology. 1985 Jul;117(1):8–12. doi: 10.1210/endo-117-1-8. [DOI] [PubMed] [Google Scholar]
  44. Momotani N., Ito K., Hamada N., Ban Y., Nishikawa Y., Mimura T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 1984 Jun;20(6):695–700. doi: 10.1111/j.1365-2265.1984.tb00119.x. [DOI] [PubMed] [Google Scholar]
  45. Mortimer R. H., Tyack S. A., Galligan J. P., Perry-Keene D. A., Tan Y. M. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Clin Endocrinol (Oxf) 1990 Feb;32(2):141–152. doi: 10.1111/j.1365-2265.1990.tb00850.x. [DOI] [PubMed] [Google Scholar]
  46. Mujtaba Q., Burrow G. N. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol. 1975 Sep;46(3):282–286. [PubMed] [Google Scholar]
  47. Munro D. S., Dirmikis S. M., Humphries H., Smith T., Broadhead G. D. The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis. Br J Obstet Gynaecol. 1978 Nov;85(11):837–843. doi: 10.1111/j.1471-0528.1978.tb15839.x. [DOI] [PubMed] [Google Scholar]
  48. O'Hearlihy C. Neonatal thyrotoxicosis with long acting thyroid stimulator-protector. Ir Med J. 1977 Mar 31;70(4):124–125. [PubMed] [Google Scholar]
  49. Paul D. A., Leef K. H., Stefano J. L., Bartoshesky L. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants. Pediatrics. 1998 May;101(5):903–907. doi: 10.1542/peds.101.5.903. [DOI] [PubMed] [Google Scholar]
  50. Pavelka S., Kopecký P., Bendlová B., Stolba P., Vítková I., Vobruba V., Plavka R., Houstek J., Kopecký J. Tissue metabolism and plasma levels of thyroid hormones in critically ill very premature infants. Pediatr Res. 1997 Dec;42(6):812–818. doi: 10.1203/00006450-199712000-00016. [DOI] [PubMed] [Google Scholar]
  51. Polk D. H., Reviczky A., Wu S. Y., Huang W. S., Fisher D. A. Metabolism of sulfoconjugated thyroid hormone derivatives in developing sheep. Am J Physiol. 1994 Jun;266(6 Pt 1):E892–E896. doi: 10.1152/ajpendo.1994.266.6.E892. [DOI] [PubMed] [Google Scholar]
  52. Rapaport R., Rose S. R., Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr. 2001 Aug;139(2):182–188. doi: 10.1067/mpd.2001.116934. [DOI] [PubMed] [Google Scholar]
  53. Reuss M. L., Paneth N., Pinto-Martin J. A., Lorenz J. M., Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med. 1996 Mar 28;334(13):821–827. doi: 10.1056/NEJM199603283341303. [DOI] [PubMed] [Google Scholar]
  54. Richard K., Hume R., Kaptein E., Sanders J. P., van Toor H., De Herder W. W., den Hollander J. C., Krenning E. P., Visser T. J. Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab. 1998 Aug;83(8):2868–2874. doi: 10.1210/jcem.83.8.5032. [DOI] [PubMed] [Google Scholar]
  55. Rooman R. P., Du Caju M. V., De Beeck L. O., Docx M., Van Reempts P., Van Acker K. J. Low thyroxinaemia occurs in the majority of very preterm newborns. Eur J Pediatr. 1996 Mar;155(3):211–215. doi: 10.1007/BF01953940. [DOI] [PubMed] [Google Scholar]
  56. Ruiz de Oña C., Morreale de Escobar G., Calvo R., Escobar del Rey F., Obregón M. J. Thyroid hormones and 5'-deiodinase in the rat fetus late in gestation: effects of maternal hypothyroidism. Endocrinology. 1991 Jan;128(1):422–432. doi: 10.1210/endo-128-1-422. [DOI] [PubMed] [Google Scholar]
  57. Samuel S., Pildes R. S., Lewison M., Rosenthal I. M. Neonatal hyperthyroidism in an infant born of an euthyroid mother. Am J Dis Child. 1971 May;121(5):440–443. doi: 10.1001/archpedi.1971.02100160110019. [DOI] [PubMed] [Google Scholar]
  58. Schwab K. O., Gerlich M., Broecker M., Söhlemann P., Derwahl M., Lohse M. J. Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr. 1997 Dec;131(6):899–904. doi: 10.1016/s0022-3476(97)70040-4. [DOI] [PubMed] [Google Scholar]
  59. Skuza K. A., Sills I. N., Stene M., Rapaport R. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease. J Pediatr. 1996 Feb;128(2):264–268. doi: 10.1016/s0022-3476(96)70405-5. [DOI] [PubMed] [Google Scholar]
  60. Spiegel A. M. The molecular basis of disorders caused by defects in G proteins. Horm Res. 1997;47(3):89–96. doi: 10.1159/000185441. [DOI] [PubMed] [Google Scholar]
  61. Sunshine P., Kusumoto H., Kriss J. P. Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics. 1965 Dec;36(6):869–876. [PubMed] [Google Scholar]
  62. Tamaki H., Amino N., Aozasa M., Mori M., Iwatani Y., Tachi J., Nose O., Tanizawa O., Miyai K. Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment. Am J Perinatol. 1988 Apr;5(2):152–158. doi: 10.1055/s-2007-999676. [DOI] [PubMed] [Google Scholar]
  63. Tamaki H., Amino N., Takeoka K., Iwatani Y., Tachi J., Kimura M., Mitsuda N., Miki K., Nose O., Tanizawa O. Prediction of later development of thyrotoxicosis or central hypothyroidism from the cord serum thyroid-stimulating hormone level in neonates born to mothers with Graves disease. J Pediatr. 1989 Aug;115(2):318–321. doi: 10.1016/s0022-3476(89)80093-9. [DOI] [PubMed] [Google Scholar]
  64. Transue D., Chan J., Kaplan M. Management of neonatal Graves disease with iopanoic acid. J Pediatr. 1992 Sep;121(3):472–474. doi: 10.1016/s0022-3476(05)81807-4. [DOI] [PubMed] [Google Scholar]
  65. Vanhole C., Aerssens P., Naulaers G., Casneuf A., Devlieger H., Van den Berghe G., de Zegher F. L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res. 1997 Jul;42(1):87–92. doi: 10.1203/00006450-199707000-00014. [DOI] [PubMed] [Google Scholar]
  66. Visser T. J. Role of sulfation in thyroid hormone metabolism. Chem Biol Interact. 1994 Jun;92(1-3):293–303. doi: 10.1016/0009-2797(94)90071-x. [DOI] [PubMed] [Google Scholar]
  67. Vulsma T., Gons M. H., de Vijlder J. J. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989 Jul 6;321(1):13–16. doi: 10.1056/NEJM198907063210103. [DOI] [PubMed] [Google Scholar]
  68. Watson W. J., Fiegen M. M. Fetal thyrotoxicosis associated with nonimmune hydrops. Am J Obstet Gynecol. 1995 Mar;172(3):1039–1040. doi: 10.1016/0002-9378(95)90040-3. [DOI] [PubMed] [Google Scholar]
  69. Weber G., Vigone M. C., Rapa A., Bona G., Chiumello G. Neonatal transient hypothyroidism: aetiological study. Italian Collaborative Study on Transient Hypothyroidism. Arch Dis Child Fetal Neonatal Ed. 1998 Jul;79(1):F70–F72. doi: 10.1136/fn.79.1.f70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Wing D. A., Millar L. K., Koonings P. P., Montoro M. N., Mestman J. H. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):90–95. doi: 10.1016/s0002-9378(94)70390-6. [DOI] [PubMed] [Google Scholar]
  71. Wit J. M., Gerards L. J., Vermeulen-Meiners C., Bruinse H. W. Neonatal thyrotoxicosis treated with exchange transfusion and Lugol's iodine. Eur J Pediatr. 1985 Mar;143(4):317–319. doi: 10.1007/BF00442312. [DOI] [PubMed] [Google Scholar]
  72. Yoshimoto M., Nakayama M., Baba T., Uehara Y., Niikawa N., Ito M., Tsuji Y. A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand. 1991 Oct;80(10):984–987. doi: 10.1111/j.1651-2227.1991.tb11769.x. [DOI] [PubMed] [Google Scholar]
  73. Zakarija M., McKenzie J. M., Hoffman W. H. Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab. 1986 Feb;62(2):368–371. doi: 10.1210/jcem-62-2-368. [DOI] [PubMed] [Google Scholar]
  74. Zakarija M., McKenzie J. M., Munro D. S. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. J Clin Invest. 1983 Oct;72(4):1352–1356. doi: 10.1172/JCI111091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Zakarija M., McKenzie J. M. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab. 1983 Nov;57(5):1036–1040. doi: 10.1210/jcem-57-5-1036. [DOI] [PubMed] [Google Scholar]
  76. de Roux N., Polak M., Couet J., Leger J., Czernichow P., Milgrom E., Misrahi M. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab. 1996 Jun;81(6):2023–2026. doi: 10.1210/jcem.81.6.8964822. [DOI] [PubMed] [Google Scholar]
  77. de Zegher F., Pernasetti F., Vanhole C., Devlieger H., Van den Berghe G., Martial J. A. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab. 1995 Nov;80(11):3127–3130. doi: 10.1210/jcem.80.11.7593413. [DOI] [PubMed] [Google Scholar]
  78. van Wassenaer A. G., Kok J. H., Dekker F. W., de Vijlder J. J. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res. 1997 Nov;42(5):604–609. doi: 10.1203/00006450-199711000-00009. [DOI] [PubMed] [Google Scholar]
  79. van Wassenaer A. G., Kok J. H., Endert E., Vulsma T., de Vijlder J. J. Thyroxine administration to infants of less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations. Acta Endocrinol (Copenh) 1993 Aug;129(2):139–146. doi: 10.1530/acta.0.1290139. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES